Clinical Trial Update: A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating VC-01™ in Type 1 Diabetes Mellitus was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• VC-01™

Snippet

Sponsor: ViaCyte | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-03-24